• Exchange: NASDAQ CM
  • Sector: Technology
  • Industry: Software
  • Sub-Industry: Application Software

Simulations Plus Inc

+ Add to Watchlist


6.4500 USD 0.0700 1.07%

As of 17:20:00 ET on 12/18/2014.

Snapshot for Simulations Plus Inc (SLP)

Open: 6.5800 Day's Range: 6.2100 - 6.5800 Volume: 17,376
Previous Close: 6.5200 52wk Range: 4.8500 - 7.1500 1-Yr Rtn: +32.52%

Stock Chart for SLP

No chart data available.
  • SLP:US 6.4500
  • 1D
  • 1M
  • 1Y
Interactive SLP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLP

Current P/E Ratio (ttm) 35.1499
Estimated P/E(08/2015) 26.3265
Relative P/E vs. SPX 1.9959
Earnings Per Share (USD) (ttm) 0.1835
Est. EPS (USD) (08/2015) 0.2450
Est. PEG Ratio 1.3163
Market Cap (M USD) 108.63
Shares Outstanding (M) 16.84
30 Day Average Volume 10,657
Price/Book (mrq) 6.8322
Price/Sale (ttm) 9.0962
Dividend Indicated Gross Yield 3.10%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 11/05/2014
5 Year Dividend Growth -
Next Earnings Announcement 01/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SLP

Simulations Plus, Inc. develops drug discovery and development simulation software, which is licensed to and used in the conduct of drug research for pharmaceutical companies worldwide. The Company's other businesses are based on its proprietary software technologies and provide support for the emerging pharmaceutical enterprise.

Walter S Woltosz "Walt"Chairman/CEO/Co-FounderThaddeus H Grasela "Ted"President
John R KneiselChief Financial OfficerMichael BolgerChief Scientist
More Company Profile & Key Executives for SLP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil